Cargando…
Chimeric antigen receptor T-cell therapy: challenges and opportunities in lung cancer
Chimeric antigen receptor (CAR) T-cell therapy has revolutionized the paradigm in hematological malignancies treatment, driving an ever-expanding number of basic research and clinical trials of genetically engineering T cells to treat solid tumors. CAR T-cell therapies based on the antibodies target...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972219/ https://www.ncbi.nlm.nih.gov/pubmed/35372786 http://dx.doi.org/10.1093/abt/tbac006 |